Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial
Sabrina Bajwah, David C. Currow, Simon P. Hart, Sharon Tuck et al.
Citations
6 citations
Journal
The Lancet Respiratory Medicine
Topics
Neuroscience of respiration and sleep
Field-Weighted Citation Impact (FWCI)
5.49
article
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial
Sabrina Bajwah, David C. Currow, Simon P. Hart, Sharon Tuck, Judith Cohen, S. A. Barrett, Joanna Bowden, Annie Jones, Gareth Stewart, Gareth Walters, Nazia Chaudhuri, Marek Atter, Mark Pearson, Marie Fallon, Peter S Hall, Bronwen Williams, John Norrie, Pilar Rivera‐Ortega, Rachael A Evans, Catriona Keerie, Miriam J. Johnson, Hannah Bayes, Irene J Higginson, Alison Boland, J. Lynn Palmer
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Respiratory MedicineVol. 13(11)
Institutions
Queen's University Belfast (GB), University of Ulster (GB), Flinders University (AU), King's College London (GB), University of Hull (GB), Edinburgh Cancer Research (GB), Flinders Medical Centre (AU), Cicely Saunders International (GB), NIHR Leicester Biomedical Research Centre (GB), Hull York Medical School (GB), University of Edinburgh (GB)
Funders
National Institute for Health and Care Research, Department of Health and Social Care, Health Technology Assessment Programme